Advanced Imaging Technology Promotes Unprecedented Precision in Prostate Biopsy
MedStar Georgetown University Hospital can now identify and analyze suspicious prostate lesions with heightened precision and less trauma to the patient with new UroNav® Fusion Biopsy System image guided biopsy.
Developed by NIH, UroNav fuses pre-biopsy MRIs of the prostate with ultrasound-guided biopsy images in real time for greater visualization and enhanced accuracy. Electronic tracking on the probe lets UroNav maintain imaging integrity even with patient movement. Among the benefits to patients, the biopsy system’s precision means, fewer tissue samples are needed, reducing the risk of infections, bleeding, pain and recovery time.
Primary candidates are patients with rising PSA levels and previously negative biopsies or those on active surveillance.
Comprehensive Prostate Cancer Care
Affiliated with the Lombardi Comprehensive Cancer Center— one of only 41 centers nationwide designated by the NCI and the sole site in the area—MedStar Georgetown features a complete array of advanced therapies. We provide patients with the least invasive therapies possible to achieve the best outcomes and the fewest side effects, including:
- Hormone therapy
- Radiation (including CyberKnife)
- Surgery (including robot-assisted surgery)
- Targeted therapy
- Active surveillance
- Clinical trials
Learn more about prostate cancer care at MedStar Georgetown.